Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24044123 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Parameswaran Grace Luther Lalitkumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division for Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet, SE 17176 Stockholm, Sweden. Hauptthemen laut MEDLINE: Medroxyprogesterone Acetate, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Karolinska Institutet/Stockholm County-council, Besins International, Brussels, Belgium.
Abstract (Originalsprache)
Recent studies suggest estradiol (E2)/natural progesterone (P) confers less breast cancer risk compared with conjugated equine estrogens (CEE)/synthetic progestogens. We investigate if differences in the regulation of breast cancer-related gene expression could provide some explanation. This study is a subset of a monocentric, 2-way, open observer-blinded, phase 4 randomized controlled trial on healthy postmenopausal women with climacteric symptoms (ClinicalTrials.gov; EUCTR-2005/001016-51). Study medication was two 28-day cycles of sequential hormone treatment with oral 0.625 mg CEE and 5 mg of oral medroxyprogesterone acetate (MPA) or 1.5 mg E2 as percutaneous gel/day with the addition of 200 mg oral micronized P. MPA and P were added days 15–28/cycle. Material from two core-needle breast biopsies in 15 women in each group was subject to quantitative PCR (Q-PCR). The primary endpoint was a change in breast carcinoma development gene expression. In the first eight consecutive women, RNA was extracted at baseline and after two months of treatment and subjected to microarray for 28856 genes and Ingenuity Pathways Analysis (IPA) to identify risk factor genes. Microarray analysis showed 3272 genes regulated with a fold-change of >±1.4. IPA showed 225 genes belonging to mammary-tumor development function: 198 for CEE/MPA vs. 34 for E2/P. Sixteen genes involved in mammary tumor inclination were subject to Q-PCR, inclining the CEE/MPA group towards an increased risk for breast carcinoma compared to the E2/P group at a very high significance level (p = 3.1 × 10−8, z-score 1.94). The combination of E2/P affected breast cancer-related genes much less than CEE/MPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division for Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet, SE 17176 Stockholm, Sweden.
- Department of Pathology, Cytology Karolinska Institutet, SE 17176 Stockholm, Sweden.
ORCID-Profile: Parameswaran Grace Luther Lalitkumar, Edneia Tani, Gunnar Söderqvist
Förderung
- Swedish Research Council
- Karolinska Institutet/Stockholm County-council
- Besins International, Brussels, Belgium
Zitieren
APA
Lalitkumar, P. G. L., Lundström, E., Byström, B., Ujvari, D., Murkes, D., Tani, E., & Söderqvist, G. (2023). Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044123
Vancouver
Lalitkumar PGL, Lundström E, Byström B, Ujvari D, Murkes D, Tani E, et al. Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044123
BibTeX
@article{Lalitkumar2023,
author = {Lalitkumar, Parameswaran Grace Luther and Lundström, Eva and Byström, Birgitta and Ujvari, Dorina and Murkes, Daniel and Tani, Edneia and Söderqvist, Gunnar},
title = {Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24044123}
}
EUVIMED